Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Monitoring the prevalence of HIV.

Literature DB >> 2513926

Monitoring the prevalence of HIV.

O N Gill¹, M W Adler, N E Day.

Abstract

Keywords: Health Care and Public Health

Mesh：

Year: 1989 PMID： 2513926 PMCID： PMC1838195 DOI： 10.1136/bmj.299.6711.1295

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

× No keyword cloud information.

25 in total

1. Rubella susceptibility and the continuing risk of infection in pregnancy.

Authors: C L Miller; E Miller; P A Waight
Journal: Br Med J (Clin Res Ed) Date: 1987-05-16

2. Failure of voluntary testing for human immunodeficiency virus to identify infected parturient women in a high-risk population.

Authors: K Krasinski; W Borkowsky; D Bebenroth; T Moore
Journal: N Engl J Med Date: 1988-01-21 Impact factor: 91.245

3. Human T-lymphotropic virus type III/lymphadenopathy-associated virus antibody testing at alternate sites.

Authors:
Journal: MMWR Morb Mortal Wkly Rep Date: 1986-05-02 Impact factor: 17.586

4. HIV prevalence data mount, patterns seen emerging by end of this year.

Authors: M F Goldsmith
Journal: JAMA Date: 1988-10-07 Impact factor: 56.272

5. HIV testing on all pregnant women.

Authors: D Black; W Bodmer; D Cox; R Doll; J Durbin; R Hoffenberg; J Kingman; J Peto; R Weiss
Journal: Lancet Date: 1987-11-28 Impact factor: 79.321

6. Anonymous testing of women attending antenatal clinics for evidence of infection with HIV.

Authors: R B Heath; P C Grint; A E Hardiman
Journal: Lancet Date: 1988-06-18 Impact factor: 79.321

7. HIV antibody screening of blood donations in the United Kingdom.

Authors: H H Gunson; V I Rawlinson
Journal: Vox Sang Date: 1988 Impact factor: 2.144

8. Serosurvey of human immunodeficiency virus infection in parturients. Implications for human immunodeficiency virus testing programs of pregnant women.

Authors: S Landesman; H Minkoff; S Holman; S McCalla; O Sijin
Journal: JAMA Date: 1987-11-20 Impact factor: 56.272

9. Seroprevalence of human immunodeficiency virus among childbearing women. Estimation by testing samples of blood from newborns.

Authors: R Hoff; V P Berardi; B J Weiblen; L Mahoney-Trout; M L Mitchell; G F Grady
Journal: N Engl J Med Date: 1988-03-03 Impact factor: 91.245

7. Prevalence of HIV among childbearing women and women having termination of pregnancy: multidisciplinary steering group study.

Authors: D J Goldberg; H MacKinnon; R Smith; N B Patel; J B Scrimgeour; J M Inglis; J F Peutherer; G E Urquhart; J A Emslie; R G Covell
Journal: BMJ Date: 1992-04-25

8. Revised guidelines on ethical and legal considerations in anonymous unlinked HIV seroprevalence research. Federal Centre for AIDS Working Group on Anonymous Unlinked HIV Seroprevalence Research.

Authors:
Journal: CMAJ Date: 1992-05-15 Impact factor: 8.262

9. Trends in sexual behaviour and HIV testing among women presenting at a genitourinary medicine clinic during the advent of AIDS.

Authors: B A Evans; S M McCormack; R A Bond; K D MacRae
Journal: Genitourin Med Date: 1991-06

10. AIDS surveillance in Africa.

Authors: A Nicoll; J Killewo
Journal: BMJ Date: 1991-11-09

Monitoring the prevalence of HIV.

1. Rubella susceptibility and the continuing risk of infection in pregnancy.

2. Failure of voluntary testing for human immunodeficiency virus to identify infected parturient women in a high-risk population.

3. Human T-lymphotropic virus type III/lymphadenopathy-associated virus antibody testing at alternate sites.

4. HIV prevalence data mount, patterns seen emerging by end of this year.

5. HIV testing on all pregnant women.

6. Anonymous testing of women attending antenatal clinics for evidence of infection with HIV.

7. HIV antibody screening of blood donations in the United Kingdom.

8. Serosurvey of human immunodeficiency virus infection in parturients. Implications for human immunodeficiency virus testing programs of pregnant women.

9. Seroprevalence of human immunodeficiency virus among childbearing women. Estimation by testing samples of blood from newborns.

10. Comparison of HIV-antibody prevalence in patients consenting to and declining HIV-antibody testing in an STD clinic.

Review 1. The ethics of anonymized HIV testing of pregnant women: a reappraisal.

2. The ethics of unlinked anonymous testing. Surveys provide essential information.

3. Bad blood? Survey of public's views on unlinked anonymous testing of blood for HIV and other diseases.

4. [HIV infection: feasibility of a seroprevalence study with consent of hospitalized patients].

5. HIV surveillance: the value of audit.

6. Monitoring the prevalence of HIV.

7. Prevalence of HIV among childbearing women and women having termination of pregnancy: multidisciplinary steering group study.

8. Revised guidelines on ethical and legal considerations in anonymous unlinked HIV seroprevalence research. Federal Centre for AIDS Working Group on Anonymous Unlinked HIV Seroprevalence Research.

9. Trends in sexual behaviour and HIV testing among women presenting at a genitourinary medicine clinic during the advent of AIDS.

10. AIDS surveillance in Africa.